Wells Fargo Maintains Overweight on HealthEquity, Raises Price Target to $93
Portfolio Pulse from Benzinga Newsdesk
Wells Fargo analyst Stan Berenshteyn has maintained an Overweight rating on HealthEquity (NASDAQ:HQY) and increased the price target from $89 to $93.
December 06, 2023 | 5:27 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Wells Fargo analyst Stan Berenshteyn reaffirmed an Overweight rating on HealthEquity and raised the price target to $93, indicating a positive outlook on the stock.
The increase in price target by a major financial institution like Wells Fargo typically signals a strong conviction in the company's future performance and can lead to increased investor confidence, potentially driving the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100